Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025)
Equillium's (EQ) quarterly Change in Acquisitions & Divestments came in at $4.5 million in Q1 2025, little changed year-on-year from $4.5 million in Q1 2024, and down 25.0% on a QoQ basis from $6.0 million in Q4 2024.
Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025) Analysis & Trends
Equillium (EQ) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $4.5 million in Q1 2025.
- On a quarterly basis, Change in Acquisitions & Divestments changed 0.0% year-over-year to $4.5 million in Q1 2025; TTM through Dec 2025 was $4.5 million, a 85.71% decrease from a year earlier, with the FY2025 full-year figure at $4.5 million, down 85.71% from the prior year.
- Change in Acquisitions & Divestments for Q1 2025 stood at $4.5 million, down from $6.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for EQ reached as high as $29.0 million in Q2 2021 and fell as low as $2.5 million in Q4 2021.
- Historically, Change in Acquisitions & Divestments has averaged $10.6 million across 5 years, with a median of $11.0 million in 2023.
- Across the five-year window, Change in Acquisitions & Divestments tumbled 79.94% in 2022 and soared 380.0% in 2023, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $2.5 million in 2021, then surged by 179.2% to $7.0 million in 2022, then jumped by 71.92% to $12.0 million in 2023, then slumped by 50.0% to $6.0 million in 2024, then slipped by 25.0% to $4.5 million in 2025.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $4.5 million in Q1 2025, $6.0 million in Q4 2024, and $12.0 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Dec 31, 2022 | 6.98 Mn |